The knowledge and attitude of Ghanaian decision-makers and researchers towards health technology assessment

Social Science & Medicine
Rebecca AddoStephen Goodall

Abstract

Although health technology assessment (HTA) is intended to provide policymakers with objective information, the likelihood that a health decision-maker (HDM) will use this information is associated with their knowledge, role and perception of the HTA process. In Ghana, policymakers are working towards formalising the use of HTA, but HDM knowledge of and attitude towards HTA are not known. Between March and May 2016, we conducted in-depth interviews and used inductive thematic analysis to explore Ghanaian HDMs (n = 23) and researchers' (n = 4) perceptions of and barriers to HTA and identify ways to promote HTA. We compare our findings with those reported in previous studies conducted in low-and-middle-income countries. Common themes were that resources, political and cultural factors act as barriers to HTA use. Recommendations made in previous studies which were also identified in this study included the need for the development of both human and data capacity, allocating funds to HTA and stakeholder involvement in HTA processes. Specific recommendations made by Ghanaian HDMs and researchers in this study focused on the establishment of an HTA body: its location, the constitution of the appraisal team, the type of evidence to ap...Continue Reading

References

Jun 23, 2000·Health Policy·C Hoffmann, J M Graf von der Schulenburg
Mar 29, 2002·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Christiane HoffmannMichael F Drummond
Jun 5, 2004·International Journal of Technology Assessment in Health Care·Adam OliverRay Robinson
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Cynthia P IglesiasUNKNOWN NEVALAT Project Group
Feb 24, 2006·Health Economics·Rob BaltussenMoses Aikins
Apr 1, 2006·Medical Education·Barbara Dicicco-Bloom, Benjamin F Crabtree
May 12, 2007·International Journal of Technology Assessment in Health Care·Adolfo RubinsteinVilda Discacciati
Sep 18, 2007·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Allison TongJonathan Craig
Jan 15, 2008·Health Policy·Oya Eddama, Joanna Coast
Apr 17, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yot Teerawattananon, Steve Russell
Jul 10, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jomkwan YothasamutYot Teerawattananon
Jul 10, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Usa ChaikledkaewViroj Tangcharoensathien
Jul 20, 2010·BMJ : British Medical Journal·Kalipso ChalkidouAndrew Dillon
Aug 30, 2011·Australian Health Review : a Publication of the Australian Hospital Association·Abdolvahab BaghbanianFreidoon A Khavarpour
Oct 1, 2011·Expert Review of Pharmacoeconomics & Outcomes Research·Feng XieRon Goeree
Jan 10, 2012·Health Economics, Policy, and Law·Corinna Sorenson, Kalipso Chalkidou
Sep 23, 2014·PLoS Medicine·Frank NyonatorSelassi d'Almeida
Dec 4, 2014·Health Research Policy and Systems·Christine KrizaPeter L Kolominsky-Rabas
Jan 15, 2015·Applied Health Economics and Health Policy·Jacqueline Cumming
May 1, 2016·BMJ Quality & Safety·Cecilia Vindrola-PadrosNaomi J Fulop
Sep 18, 2016·Applied Health Economics and Health Policy·Elias Asfaw ZegeyeThomas Wilkinson
Oct 4, 2016·International Journal of Technology Assessment in Health Care·Hector Eduardo Castro JaramilloDiana Osorio-Cuevas
Nov 21, 2017·International Journal of Technology Assessment in Health Care·Kirstin OzturkOlgun Şener
May 1, 2014·Value in Health Regional Issues·Bhavesh JainSilvia M Evers
Jun 26, 2018·Quality & Quantity·Benjamin SaundersClare Jinks

❮ Previous
Next ❯

Citations

Jul 9, 2021·Cost Effectiveness and Resource Allocation : C/E·Samantha HollingworthKalipso Chalkidou
Aug 28, 2021·International Journal of Environmental Research and Public Health·Hwa-Young LeeWoong-Han Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Health Research Policy and Systems
Bahareh YazdizadehAshraf Velayati
International Journal of Technology Assessment in Health Care
Valentina Prevolnik Rupel
International Journal of Technology Assessment in Health Care
Hector Eduardo Castro JaramilloDiana Osorio-Cuevas
© 2021 Meta ULC. All rights reserved